PLX3397 (another CSF-1R inhibitor) markedly suppresses glioma cell proliferation and invasion and reduces the grade of malignancy in a PDGF-B-driven proneural glioma mouse model 106. This evidence concerns the gene CSF1R and central nervous system cancer.